NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
+19.71%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.88B
AUM Growth
+$2.88B
Cap. Flow
-$9.3M
Cap. Flow %
-0.32%
Top 10 Hldgs %
84.68%
Holding
41
New
2
Increased
5
Reduced
4
Closed
3

Sector Composition

1 Healthcare 84.57%
2 Technology 2.48%
3 Communication Services 2.06%
4 Consumer Discretionary 1.42%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AFMD
26
DELISTED
Affimed
AFMD
$8.94M 0.31%
+388,889
New +$8.94M
SYBX icon
27
Synlogic
SYBX
$17.4M
$6.52M 0.23%
28,332
DZSI
28
DELISTED
DZS Inc. Common Stock
DZSI
$5.97M 0.21%
956,255
-3
-0% -$19
VIRX
29
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$5.32M 0.19%
37,094
AKTX
30
Akari Therapeutics
AKTX
$21.4M
$5.01M 0.17%
22,608
CSBR icon
31
Champions Oncology
CSBR
$95.8M
$4.95M 0.17%
1,562,500
ORKA
32
Oruka Therapeutics, Inc. Common Stock
ORKA
$578M
$3.72M 0.13%
6,760
ROKA
33
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$3.18M 0.11%
893,471
ARQL
34
DELISTED
Arqule Inc
ARQL
$2.67M 0.09%
2,520,316
OREX
35
DELISTED
Orexigen Therapeutics, Inc.
OREX
$1.28M 0.04%
370,900
PRTK
36
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.28M 0.04%
66,245
GYRE icon
37
Gyre Therapeutics
GYRE
$734M
$410K 0.01%
5,799
AVTX icon
38
Avalo Therapeutics
AVTX
$139M
$402K 0.01%
207
AGRX
39
DELISTED
Agile Therapeutics, Inc
AGRX
-67
Closed -$761K
CLVS
40
DELISTED
Clovis Oncology, Inc.
CLVS
-1,139,890
Closed -$50.6M
ZSAN
41
DELISTED
Zosano Pharma Corporation
ZSAN
-2,933
Closed -$1.6M